CN105287724A - Medicine for treating facioplegia - Google Patents

Medicine for treating facioplegia Download PDF

Info

Publication number
CN105287724A
CN105287724A CN201410263350.7A CN201410263350A CN105287724A CN 105287724 A CN105287724 A CN 105287724A CN 201410263350 A CN201410263350 A CN 201410263350A CN 105287724 A CN105287724 A CN 105287724A
Authority
CN
China
Prior art keywords
parts
medicine
treating
facioplegia
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410263350.7A
Other languages
Chinese (zh)
Inventor
张红伶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410263350.7A priority Critical patent/CN105287724A/en
Publication of CN105287724A publication Critical patent/CN105287724A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for treating facioplegia. The medicine for treating facioplegia is prepared from the following raw materials in part by weight: 3-8 parts of scorpio, 12-18 parts of bombyx batryticatus, 15-20 parts of Astragalus membranaceus, 20-30 parts of gypsum, 4-8 parts of cassia twig and 12-18 parts of Rhizoma Atractylodis Macrocephalae. In the medicine for treating facioplegia, six natural traditional Chinese medicines are selected to be compatible, various raw herbal materials have synergistic effect, effects of clearing heat and cooling blood, purging fire for removing toxin, moisturizing dryness by nourishing yin, tonifying stomach and promoting fluid, dispelling wind and relieving convulsion, calming wind and dredging collaterals, resolving tetany and relieving pain, promoting blood circulation to remove blood stasis, strengthening body resistance and eliminating evil and the like are achieved, viruses are inhibited, simultaneous treatment of principal and subordinate symptoms is realized, an effect of treating facioplegi is good, and toxic or side effects are avoided. Moreover, a preparation method of the medicine is simple, a course of treatment is short, the medicine is convenient to take orally, the cost is low, and the effective rate is above 85%.

Description

One treats prosopoplegic medicine
Technical field
The present invention relates to Chinese medicine, specifically one treats prosopoplegic medicine.
Background technology
Facial paralysis, be a kind of commonly encountered diseases that is principal character with facial expression muscle group dyskinesia, it is divided into peripheral and central two kinds.General symptom is facial hemiparalysis.It is a kind of commonly encountered diseases, frequently-occurring disease, not by age limit.Modern medicine mainly adopts the method treatments such as hormone, vitamin B group and physical therapy, as vitamin B 1, B 6, B 12, Gun bis-phosphorus choline or Radix Salviae Miltiorrhizae Injection, the injection of ginseng arteries and veins etc.
These methods can only be cured the symptoms, not the disease mostly, and therapeutic effect is not obvious, take effect slow, treatment cycle is long, easily leaves sequela, causes that Relapse rate is difficult heals.Modern clinic generally believe the combination of Chinese and Western medicine particularly this disease for the treatment of by Chinese herbs be first-selected therapy.
Summary of the invention
The prosopoplegic medicine for the treatment of the object of this invention is to provide a kind of good effect, the course for the treatment of is shorter, cost is low, having no side effect.
The technical scheme realizing the object of the invention is:
One treats prosopoplegic medicine, is to be made up of the raw material of following weight proportioning:
Scorpio 3-8 part, Bombyx Batryticatus 12-18 part, Radix Astragali 15-20 part, Gypsum Fibrosum 20-30 part, Ramulus Cinnamomi 4-8 part, Rhizoma Atractylodis Macrocephalae 12-18 part.
Preferably, the optimum weight proportioning of each raw material is:
Scorpio 5 parts, Bombyx Batryticatus 15 parts, the Radix Astragali 18 parts, 24 parts, Gypsum Fibrosum, Ramulus Cinnamomi 6 parts, the Rhizoma Atractylodis Macrocephalae 15 parts.
Described crude drug is in shop of Chinese medicines and commercially available.
The preparation method of medicine of the present invention, can decoct into decoction according to a conventional method, and concrete grammar is: take each crude drug by weight ratio, adds the water of 5-10 times of crude drug total amount, boils rear slow fire and boils 10-20 minute, filter and remove residue, to obtain final product with big fire.
Instructions of taking: every day 2 times, each 25 milliliters, general 6-8 day and effective.
Medicine of the present invention also can be made into pill, powder or capsule.
In the present invention, effect of each crude drug is as follows:
Scorpio: acrid in the mouth, property are flat, poisonous, return Liver Channel.There is effect of suppressing the hyperactive liver to relieve the wind syndrome, endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain.
Bombyx Batryticatus: salty in the mouth, pungent, property are put down, and return liver, lung, stomach warp.There is expelling wind for relieving convulsion, effect of dissipating phlegm and resolving masses, relieving convulsion, pain relieving.Cure mainly convulsion with spasms, facial paralysis.
The Radix Astragali: sweet in the mouth, slightly warm in nature, returns lung, spleen, liver, kidney channel.There is enhancing human body immunity function, protect the liver, diuresis, defying age, anti-stress, blood pressure lowering and antibacterial action more widely.
Gypsum Fibrosum: pungent, sweet, cold nature.Attach to the lung and stomach meridians.The effects such as have clearing away heat-fire, relieving restlessness is quenched the thirst, convergence granulation promoting.
Ramulus Cinnamomi: acrid in the mouth, sweet, warm in nature, enters lung, the heart, urinary bladder channel, has effect of complement sun, promoting blood circulation, warming the spleen and stomach.
The Rhizoma Atractylodis Macrocephalae: bitter in the mouth, sweet, warm in nature, returns spleen, stomach warp.There is air making-up and spleen enlivening, dampness diuretic, hidroschesis, antiabortive effect.
The present invention treats prosopoplegic medicine and chooses 6 kinds of natural Chinese medicine compatibilities, each crude drug synergism plays the effects such as clearing away heat and cooling blood, eliminating fire and detoxication, nourishing YIN and moistening the lung, reinforcing stomach reg fluid, expelling wind for relieving convulsion, calming wind and dredging collateral, relieving spasm to stop pain, blood circulation promoting and blood stasis dispelling, strengthening vital QI to eliminate pathogenic factors, inhibitory action is had to virus, treating both the principal and the secondary aspects of a disease at the same time, effective to treatment facial paralysis, have no side effect.And its preparation method is simple, the course for the treatment of is shorter, taking convenience, cost is low, and effective percentage reaches more than 85%.
Detailed description of the invention
Below in conjunction with embodiment, content of the present invention is further described, but is not limitation of the invention.
Embodiment 1:
One treats prosopoplegic medicine, and the weight proportion of each raw material is:
Scorpio 3 parts, Bombyx Batryticatus 12 parts, the Radix Astragali 15 parts, 20 parts, Gypsum Fibrosum, Ramulus Cinnamomi 4 parts, the Rhizoma Atractylodis Macrocephalae 12 parts.Decoct into decoction oral according to a conventional method.
Embodiment 2:
One treats prosopoplegic medicine, and the weight proportion of each raw material is:
Scorpio 5 parts, Bombyx Batryticatus 15 parts, the Radix Astragali 18 parts, 24 parts, Gypsum Fibrosum, Ramulus Cinnamomi 6 parts, the Rhizoma Atractylodis Macrocephalae 15 parts.Decoct into decoction oral according to a conventional method.
Embodiment 3:
One treats prosopoplegic medicine, and the weight proportion of each raw material is:
Scorpio 8 parts, Bombyx Batryticatus 18 parts, the Radix Astragali 20 parts, 30 parts, Gypsum Fibrosum, Ramulus Cinnamomi 8 parts, the Rhizoma Atractylodis Macrocephalae 18 parts.Decoct into decoction oral according to a conventional method.
Experimental example:
In order to prove the clinical efficacy of medicine of the present invention further, selecting 20 routine patients, clinical observation is carried out to the curative effect of medicine of the present invention.
Efficacy determination based on transference cure, and changes situation with reference to effect etc., is divided into effective, effective and invalid.
Effective: symptom obviously alleviates and successful improves.
Effective: symptom and effect have certain improvement.
Invalid: symptom and sign are all without improvement or DeGrain.
Apply in Drug therapy facial paralysis 20 example of the present invention, man 12 example, female 8 example.Fundamental symptoms is: the outflow of facial muscle inconvenient activity, saliva, bicker are crooked etc. laterally.After oral Drug therapy of the present invention, symptom all has certain improvement, wherein effective 18 examples, effective 20 examples, invalid 0 example, effective percentage 100%.

Claims (2)

1. treat a prosopoplegic medicine, it is characterized in that being made up of the raw material of following weight proportioning: Scorpio 3-8 part, Bombyx Batryticatus 12-18 part, Radix Astragali 15-20 part, Gypsum Fibrosum 20-30 part, Ramulus Cinnamomi 4-8 part, Rhizoma Atractylodis Macrocephalae 12-18 part.
2. medicine according to claim 1, is characterized in that the weight proportion of each raw material is: Scorpio 5 parts, Bombyx Batryticatus 15 parts, the Radix Astragali 18 parts, 24 parts, Gypsum Fibrosum, Ramulus Cinnamomi 6 parts, the Rhizoma Atractylodis Macrocephalae 15 parts.
CN201410263350.7A 2014-06-15 2014-06-15 Medicine for treating facioplegia Pending CN105287724A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410263350.7A CN105287724A (en) 2014-06-15 2014-06-15 Medicine for treating facioplegia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410263350.7A CN105287724A (en) 2014-06-15 2014-06-15 Medicine for treating facioplegia

Publications (1)

Publication Number Publication Date
CN105287724A true CN105287724A (en) 2016-02-03

Family

ID=55186011

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410263350.7A Pending CN105287724A (en) 2014-06-15 2014-06-15 Medicine for treating facioplegia

Country Status (1)

Country Link
CN (1) CN105287724A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110075070A (en) * 2019-05-09 2019-08-02 安徽中医药大学第一附属医院 Seven taste face networks of one kind lead to particle and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101057940A (en) * 2007-05-31 2007-10-24 徐明波 Apoplexy recover pills
CN101543558A (en) * 2008-03-28 2009-09-30 天科仁祥技术(北京)有限责任公司 Medicine composition for treating facioplegia and preparation method thereof
CN101940675A (en) * 2010-09-10 2011-01-12 重庆市南川区金佛山中药材品种培育研究所 Chinese medicinal herb for treating facial neuritis
CN101991638A (en) * 2010-11-26 2011-03-30 潘畅 Medicine composition for treating facial paralysis as well as preparation method and application thereof
CN103285264A (en) * 2013-06-09 2013-09-11 刘芹 Traditional Chinese medicinal preparation for treating facial paralysis, and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101057940A (en) * 2007-05-31 2007-10-24 徐明波 Apoplexy recover pills
CN101543558A (en) * 2008-03-28 2009-09-30 天科仁祥技术(北京)有限责任公司 Medicine composition for treating facioplegia and preparation method thereof
CN101940675A (en) * 2010-09-10 2011-01-12 重庆市南川区金佛山中药材品种培育研究所 Chinese medicinal herb for treating facial neuritis
CN101991638A (en) * 2010-11-26 2011-03-30 潘畅 Medicine composition for treating facial paralysis as well as preparation method and application thereof
CN103285264A (en) * 2013-06-09 2013-09-11 刘芹 Traditional Chinese medicinal preparation for treating facial paralysis, and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110075070A (en) * 2019-05-09 2019-08-02 安徽中医药大学第一附属医院 Seven taste face networks of one kind lead to particle and preparation method thereof

Similar Documents

Publication Publication Date Title
CN104984316A (en) Medicine for treating female cold in uterus
CN103623157A (en) Medicine for treating facial paralysis
CN104000893A (en) Traditional Chinese medicine oral liquid for treating rhinitis
CN103041271B (en) Traditional Chinese medicine composition for treating emphysema
CN102100817A (en) Chinese medicinal preparation for treating infection of upper respiratory tracts
CN105311420A (en) Traditional Chinese medicine composition for treating stroke and sequelae thereof
CN104689144A (en) Drug for treating rheumatoid arthritis
CN105287724A (en) Medicine for treating facioplegia
CN105031087A (en) Medical wine with effects of dispelling wind and removing dampness and manufacturing method of medical wine
CN105311460A (en) Traditional Chinese medicine for treating vascular neuralgia headache
CN103860954A (en) Traditional Chinese medicine combination for treating nondisplaced clavicular fracture
CN106176996A (en) A kind of Chinese medicine composition of facial paralysis
CN106511611A (en) Medicinal liquor for treatment of rheumatic cold disease of joints
CN105250956A (en) Chinese herb composition for treating colitis
CN105213985A (en) A kind of Chinese medicine decoction for the treatment of syndrome of marrow depletion due to kidney deficiency type cranial tinnitus
CN105327314A (en) Arthritis tincture for treating rheumatism and rheumatoid and preparation method thereof
CN106266041A (en) A kind of Chinese medicine composition treating menoxenia
CN104758554A (en) Traditional Chinese medicine composition for treating headache
CN105213522A (en) A kind of medicine for the treatment of dysentery
CN109771624A (en) A kind of Chinese medicine composition for treating apoplexy
CN104491480A (en) Rheumatalgia-relieving and collaterals-activating wine and preparation method thereof
CN104189815A (en) Traditional Chinese medicine preparation for treating children bronchial asthma
CN105362452A (en) Medicine for treating Raynaud disease
CN104013949A (en) Traditional Chinese medicine preparation for treating epilepsy
CN104127557A (en) Traditional Chinese medicine for treating liver cirrhosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160203

WD01 Invention patent application deemed withdrawn after publication